Zobrazeno 1 - 10
of 192
pro vyhledávání: '"M Amonkar"'
Autor:
Mayur M. Amonkar, Monica Chase, Nicole M. Myer, Tongtong Wang, Vladimir Turzhitsky, Alexander Spira
Publikováno v:
Cancer Treatment and Research Communications, Vol 36, Iss , Pp 100712- (2023)
Micro Abstract: This retrospective observational study assessed real-world treatment patterns and clinical outcomes among first-line MSI-H/dMMR metastatic colorectal cancer patients. Of 150 patients in the study cohort, 38.7% were treated with chemot
Externí odkaz:
https://doaj.org/article/6d365d29da024c2e9759671b9448161c
Autor:
Gaurang M. Amonkar, Richard Wagner, Kamakshi Bankoti, Jessica E. Shui, Xingbin Ai, Paul H. Lerou
Publikováno v:
STAR Protocols, Vol 3, Iss 2, Pp 101390- (2022)
Summary: Patient-specific airway basal stem cells (BSCs) can be derived from tracheal aspirate (TA) samples from intubated patients, thus providing an invaluable lung stem cell derivation method that bypasses the need for lung tissue. The primary cul
Externí odkaz:
https://doaj.org/article/b034a18d198e474e8fbf9b4e3455547d
Autor:
Michele Maio, Mayur M. Amonkar, Josephine M. Norquist, Paolo A. Ascierto, Ludmila Manzyuk, Daniel Motola-Kuba, Nicolas Penel, Philippe A. Cassier, Giovanni M. Bariani, Ana De Jesus Acosta, Toshihiko Doi, Federico Longo, Wilson H. Miller, Do-Youn Oh, Maya Gottfried, Ruixue Wang, Kevin Norwood, Aurelien Marabelle
Publikováno v:
European Journal of Cancer. 169:188-197
In the KEYNOTE-158 study (NCT02628067), pembrolizumab showed a high objective response rate and durable clinical benefit for patients with previously treated, unresectable/metastatic microsatellite instability-high (MSI-H)/mismatch repair‒deficient
Autor:
Lauren A. Abderhalden, Ping Wu, Mayur M. Amonkar, Brian M. Lang, Sukrut Shah, Fan Jin, Andrew M. Frederickson, Ali Mojebi
Publikováno v:
Journal of Gastrointestinal Cancer.
Purpose Although second-line treatments improve survival compared to best supportive care in patients with advanced gastric cancer with disease progression on first-line therapy, prognosis remains poor. A systematic review and meta-analysis were cond
Autor:
Florentine Dylong, Jan Riedel, Gaurang M. Amonkar, Nicole Peukert, Paula Lieckfeldt, Katinka Sturm, Benedikt Höxter, Wai Hei Tse, Yuichiro Miyake, Steffi Mayer, Richard Keijzer, Martin Lacher, Xingbin Ai, Jan-Hendrik Gosemann, Richard Wagner
Background & ObjectiveAbnormal lung development is the main cause of morbidity and mortality in neonates with congenital diaphragmatic hernia (CDH), a common birth defect (1:2500) of largely unknown pathobiology. Recent studies discovered that inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f2c07983fc3d43d8d982e13c351cacf
https://doi.org/10.1101/2023.04.07.536002
https://doi.org/10.1101/2023.04.07.536002
Autor:
Mayur M. Amonkar, Lauren A. Abderhalden, Andrew M. Frederickson, Audrone Aksomaityte, Brian M. Lang, Pierre Leconte, Ina Zhang
Publikováno v:
International Journal of Colorectal Disease. 38
Autor:
Richard Wagner, Gaurang M. Amonkar, Wei Wang, Jessica E. Shui, Kamakshi Bankoti, Wai Hei Tse, Frances A. High, Jill M. Zalieckas, Terry L. Buchmiller, Augusto Zani, Richard Keijzer, Patricia K. Donahoe, Paul H. Lerou, Xingbin Ai
Publikováno v:
Am J Respir Crit Care Med
RationaleCongenital diaphragmatic hernia (CDH) is characterized by incomplete closure of the diaphragm and lung hypoplasia. The pathophysiology of lung defects in CDH is poorly understood.ObjectivesTo establish a translational model of human airway e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a56a4d07833c688a12e659d7062bd3da
https://doi.org/10.1101/2022.11.10.515365
https://doi.org/10.1101/2022.11.10.515365
Autor:
M Amonkar, AM Frederickson, A Aksomaityte, BM Lang, I Zhang, P Leconte, DE Adelberg, LA Abderhalden
Publikováno v:
Value in Health. 25:S39-S40
Autor:
D.M. O'Malley, G.M. Bariani, P.A. Cassier, A. Marabelle, A.R. Hansen, A. De Jesus Acosta, W.H. Miller, T. Safra, A. Italiano, L. Mileshkin, M. Amonkar, L. Yao, F. Jin, K. Norwood, M. Maio
Publikováno v:
Gynecologic oncology. 166(2)
Pembrolizumab demonstrated a clinically meaningful objective response rate in patients with previously treated, advanced MSI-H/dMMR endometrial cancer in the multicohort phase 2 KEYNOTE-158 study (ClinicalTrials.gov, NCT02628067). We present health-r
Publikováno v:
Value in Health. 25:S491